VI
AMPH icon

Versor Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Versor Investments’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,700
Closed -$733K – 714
2024
Q1 		$733K Buy
+16,700
New +$863K 0.15% 220
2023
Q4 		– Sell
-5,700
Closed -$262K – 689
2023
Q3 		$262K Buy
+5,700
New +$311K 0.05% 522
2023
Q2 		– Sell
-14,302
Closed -$536K – 612
2023
Q1 		$536K Sell
14,302
-1,498
-9% -$49.1K 0.07% 304
2022
Q4 		$443K Buy
15,800
+4,871
+45% +$141K 0.04% 384
2022
Q3 		$307K Sell
10,929
-2,071
-16% -$67.6K 0.02% 595
2022
Q2 		$452K Buy
+13,000
New +$464K 0.02% 513

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Versor Investments's AMPH Position: Q2 2024 in Review

Versor Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2024, closing a stake of 16,700 shares — an estimated $733K sold.

Versor Investments first reported a position in AMPH in Q2 2022 and held it in 6 quarters. The position peaked at $733K in Q1 2024. 269 funds tracked by Wall St. Rank hold AMPH as of Q2 2024.

  • Versor Investments reported no remaining Amphastar Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Versor Investments sold 16,700 Amphastar Pharmaceuticals shares in Q2 2024, an estimated $733K.
  • Versor Investments first reported a position in Amphastar Pharmaceuticals in Q2 2022 and held it in 6 quarters.
  • Versor Investments's Amphastar Pharmaceuticals position peaked at $733K in Q1 2024.
  • 269 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2024.

Based on Versor Investments's 13F filing for Q2 2024, filed 1 Aug 2024.